๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Oesophagus Cancer

Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux NCT06746623NA1 site๐Ÿ“ Cleveland Louis Stokes VA Medical Center ยท Tests: Enrolled participants will complete Esocheck/Esoguard and diagnostic upper endoscopy. A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors NCT06043466Phase 12 sites๐Ÿ“ Hangzhou๐Ÿ“ Hangzhou Chongqing Precision Biotech Co., Ltd ยท Tests: CEA-targeted CAR-T cells Study of Tislelizumab Combined With Chemoradiotherapy and Surgery for Unresectable Esophageal Squamous Cell Carcinoma NCT07039162Phase 28 sites๐Ÿ“ Kaohsiung City๐Ÿ“ Kaohsiung City๐Ÿ“ Taichung Ming-Yu Lien ยท Tests: Tislelizumab, Paclitaxel, Cisplatin, Radiation Therapy Rehabilitation and Recovery for Persons With Esophageal or Gastric Cancer NCT05698992n/a1 site๐Ÿ“ Lund Region Skane ยท Tests: evidence-based individualized rehabilitation Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease NCT07685938Phase 21 site๐Ÿ“ Chapel Hill UNC Lineberger Comprehensive Cancer Center ยท Tests: Atorvastatin and Lisinopril, Placebo Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice Experiment NCT06346080NA1 site๐Ÿ“ Leuven KU Leuven ยท Tests: Survey Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy NCT04892849n/a1 site๐Ÿ“ Erlangen University of Erlangen-Nรผrnberg Medical School ยท Tests: Conventional Therapy acc. to prevailing clincal approved schemes Neoadjuvant Comprehensive Treatment for Unresectable Esophageal Cancer NCT06430658Phase 21 site๐Ÿ“ Beijing Cancer Institute and Hospital, Chinese Academy of Medical Sโ€ฆ ยท Tests: Tislelizumab (BGB-A317) with chemoradiotherapy 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer NCT06298916Phase 1, Phase 25 sites๐Ÿ“ Duarte๐Ÿ“ Orange๐Ÿ“ Stanford Lantheus Medical Imaging ยท Tests: 64Cu-LNTH-1363S A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) NCT06760819Phase 254 sites๐Ÿ“ Birmingham๐Ÿ“ Duarte๐Ÿ“ Fort Myers Bayer ยท Tests: BAY2927088 Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection NCT05334069n/a747 sites๐Ÿ“ Anchorage๐Ÿ“ Anchorage๐Ÿ“ Anchorage Alliance for Clinical Trials in Oncology ยท Tests: Questionnaire Administration, Biospecimen Collection Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors NCT06239194Phase 1, Phase 26 sites๐Ÿ“ Denver๐Ÿ“ Miami๐Ÿ“ Boston ModeX Therapeutics, An OPKO Health Company ยท Tests: MDX2001 The Effect of Chronic Stress on Efficacy of ICIs in Esophageal Cancer Patients (STRESS-ESCA Study) NCT05967910n/a1 site๐Ÿ“ Changsha Second Xiangya Hospital of Central South University ยท Tests: chronic psychological stress Prospective Endoscopic Follow-up of Patients With Submucosal and High Risk Mucosal Esophageal Adenocarcinoma NCT03222635NA20 sites๐Ÿ“ Sydney๐Ÿ“ Brussels๐Ÿ“ Ghent Amsterdam UMC ยท Tests: Endoscopic follow-up Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer NCT06421376Phase 23 sites๐Ÿ“ Anyang๐Ÿ“ Xinxiang๐Ÿ“ Beijing Cancer Institute and Hospital, Chinese Academy of Medical Sโ€ฆ ยท Tests: Cardonilizumab, Chemoradiotherapy ยฑimmunotherapy, Radical surgery Total Intravenous Anesthesia and Recurrence Free Survival NCT04513808Phase 31 site๐Ÿ“ Shanghai The Cleveland Clinic ยท Tests: Propofol-based total intravenous anesthesia, Sevoflurane intravenous anesthesia Supercharged TRAM Evaluation in Cervical Esophagogastroplasty After Esophagectomy NCT05954702NA1 site๐Ÿ“ Sรฃo Paulo Instituto do Cancer do Estado de Sรฃo Paulo ยท Tests: Supercharged TRAM esophagectomy, Conventional Esophagectomy Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers NCT02584244Phase 1, Phase 21 site๐Ÿ“ Boston Lumicell, Inc. ยท Tests: LUM015, LUM 2.6 Imaging Device Comparison of Esophagectomy and Chemoradiation for Patients With cN0-pT1b Stage Esophageal Squamous Cell Carcinoma NCT04135664Phase 36 sites๐Ÿ“ Nanchang๐Ÿ“ Shanghai๐Ÿ“ Shanghai Shanghai Chest Hospital ยท Tests: esophagectomy, chemoradiation, active surveillance A Study of Sigvotatug Vedotin in Advanced Solid Tumors NCT04389632Phase 1158 sites๐Ÿ“ Anchorage๐Ÿ“ Fayetteville๐Ÿ“ Rogers Seagen, a wholly owned subsidiary of Pfizer ยท Tests: sigvotatug vedotin, pembrolizumab, cisplatin, carboplatin A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B) NCT05319730Phase 1, Phase 258 sites๐Ÿ“ Tucson๐Ÿ“ Los Angeles๐Ÿ“ East Syracuse Merck Sharp & Dohme LLC ยท Tests: Paclitaxel, Irinotecan, Pembrolizumab, MK-4830, Lenvatinib Ultralong-segment Barrett's Esophagus: Towards a Capsule-sponge Surveillance Strategy NCT06720636NA1 site๐Ÿ“ Rotterdam Erasmus Medical Center ยท Tests: EndoSign Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests NCT06693622n/a1 site๐Ÿ“ Aurora University of Colorado, Denver ยท Tests: Patient survey Predicting Esophageal Cancer Borders Using PET-Imaging NCT06408116Phase 21 site๐Ÿ“ Heidelberg University Hospital Heidelberg ยท Tests: photon, surgical therapy, Chemotherapy Retrospective Review of Esophageal Cancer at MSKCC NCT05706558n/a1 site๐Ÿ“ New York Memorial Sloan Kettering Cancer Center ยท Tests: Esophagectomy Timing of Comprehensive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma NCT07000253Phase 25 sites๐Ÿ“ Amsterdam๐Ÿ“ Utrecht๐Ÿ“ Oslo Academisch Medisch Centrum - Universiteit van Amsterdam (AMโ€ฆ ยท Tests: Chemotherapy, Targeted Systemic Therapy, Immunotherapy, Surgery, Radiotherapy Sintilimab and Chemotherapy Sequential Radiotherapy in Advanced Esophageal Cancer NCT06138028Phase 2, Phase 32 sites๐Ÿ“ Qingdao๐Ÿ“ Qingdao Qingdao Central Hospital ยท Tests: TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors๏ผˆSintilimab๏ผ‰ Impact of CES1 Genotype on Capecitabine Exposure in Cancer Patients NCT07114627n/a1 site๐Ÿ“ Rotterdam Erasmus Medical Center ยท Tests: Blood sampling for pharmacokinetics A Study in Greece Observing How Patients With Stomach and Esophageal Cancer Are Diagnosed and Treated in Everyday Medical Practice NCT07800754n/a8 sites๐Ÿ“ Alexandroupoli๐Ÿ“ Athens๐Ÿ“ Athens AstraZeneca Influence Mechanism of Tumor Microenvironment Changes on Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma NCT05894369n/a1 site๐Ÿ“ Wuhan Renmin Hospital of Wuhan University
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy